These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Return to play with hypertrophic cardiomyopathy: are we moving too fast? A critical review. Drezner JA; Malhotra A; Prutkin JM; Papadakis M; Harmon KG; Asif IM; Owens DS; Marek JC; Sharma S Br J Sports Med; 2021 Sep; 55(18):1041-1047. PubMed ID: 33472848 [TBL] [Abstract][Full Text] [Related]
4. Enhanced American College of Cardiology/American Heart Association Strategy for Prevention of Sudden Cardiac Death in High-Risk Patients With Hypertrophic Cardiomyopathy. Maron MS; Rowin EJ; Wessler BS; Mooney PJ; Fatima A; Patel P; Koethe BC; Romashko M; Link MS; Maron BJ JAMA Cardiol; 2019 Jul; 4(7):644-657. PubMed ID: 31116360 [TBL] [Abstract][Full Text] [Related]
5. Clinical outcomes in adult athletes with hypertrophic cardiomyopathy: a 7-year follow-up study. Pelliccia A; Caselli S; Pelliccia M; Musumeci MB; Lemme E; Di Paolo FM; Maestrini V; Russo D; Limite L; Borrazzo C; Autore C Br J Sports Med; 2020 Aug; 54(16):1008-1012. PubMed ID: 32532845 [TBL] [Abstract][Full Text] [Related]
6. A validation study of the 2003 American College of Cardiology/European Society of Cardiology and 2011 American College of Cardiology Foundation/American Heart Association risk stratification and treatment algorithms for sudden cardiac death in patients with hypertrophic cardiomyopathy. O'Mahony C; Tome-Esteban M; Lambiase PD; Pantazis A; Dickie S; McKenna WJ; Elliott PM Heart; 2013 Apr; 99(8):534-41. PubMed ID: 23339826 [TBL] [Abstract][Full Text] [Related]
7. Hypertrophic cardiomyopathy and competitive sports: let 'em play? Masilamani MSJ; Cannon B Curr Opin Cardiol; 2024 Jul; 39(4):308-314. PubMed ID: 38743663 [TBL] [Abstract][Full Text] [Related]
8. Improvement in sudden cardiac death risk prediction by the enhanced American College of Cardiology/American Heart Association strategy in Chinese patients with hypertrophic cardiomyopathy. Liu J; Wu G; Zhang C; Ruan J; Wang D; Zhang M; Wang L; Yang Y; Li X; Wang Y; Hui R; Zou Y; Kang L; Wang J; Song L Heart Rhythm; 2020 Oct; 17(10):1658-1663. PubMed ID: 32311532 [TBL] [Abstract][Full Text] [Related]
9. Exercise and hypertrophic cardiomyopathy: Two incompatible entities? Basu J; Malhotra A; Papadakis M Clin Cardiol; 2020 Aug; 43(8):889-896. PubMed ID: 32048747 [TBL] [Abstract][Full Text] [Related]
10. New Insights and Recommendations for Athletes With Hypertrophic Cardiomyopathy. McKinney J; Isserow M; Wong J; Isserow S; Moulson N Can J Cardiol; 2024 May; 40(5):921-933. PubMed ID: 38369259 [TBL] [Abstract][Full Text] [Related]
11. Validation of the 2014 European Society of Cardiology guidelines risk prediction model for the primary prevention of sudden cardiac death in hypertrophic cardiomyopathy. Vriesendorp PA; Schinkel AF; Liebregts M; Theuns DA; van Cleemput J; Ten Cate FJ; Willems R; Michels M Circ Arrhythm Electrophysiol; 2015 Aug; 8(4):829-35. PubMed ID: 25922410 [TBL] [Abstract][Full Text] [Related]
12. Sport practice in hypertrophic cardiomyopathy: running to stand still? Mascia G; Olivotto I; Brugada J; Arbelo E; Di Donna P; Della Bona R; Canepa M; Porto I Int J Cardiol; 2021 Dec; 345():77-82. PubMed ID: 34662670 [TBL] [Abstract][Full Text] [Related]
13. The safety of sports in children with inherited arrhythmia substrates. Katyal A; Li COY; Franciosi S; Sanatani S Front Pediatr; 2023; 11():1151286. PubMed ID: 37124180 [TBL] [Abstract][Full Text] [Related]
14. Exercise recommendations for patients with hypertrophic cardiomyopathy. Bryde R; Martinez MW; Emery MS Prog Cardiovasc Dis; 2023; 80():53-59. PubMed ID: 37201741 [TBL] [Abstract][Full Text] [Related]
15. Recommendations for participation in leisure-time physical activity and competitive sports in patients with arrhythmias and potentially arrhythmogenic conditions: Part 1: Supraventricular arrhythmias. A position statement of the Section of Sports Cardiology and Exercise from the European Association of Preventive Cardiology (EAPC) and the European Heart Rhythm Association (EHRA), both associations of the European Society of Cardiology. Heidbuchel H; Adami PE; Antz M; Braunschweig F; Delise P; Scherr D; Solberg EE; Wilhelm M; Pelliccia A; Eur J Prev Cardiol; 2021 Dec; 28(14):1539-1551. PubMed ID: 32597206 [TBL] [Abstract][Full Text] [Related]
16. Predicting therapies in Japanese hypertrophic cardiomyopathy patients with an implantable cardioverter-defibrillator using the 2014 European Society of Cardiology guidelines. Nakano M; Kondo Y; Nakano M; Kajiyama T; Miyazawa K; Hayashi T; Ito R; Takahira H; Kobayashi Y Heart Vessels; 2021 Jan; 36(1):99-104. PubMed ID: 32666207 [TBL] [Abstract][Full Text] [Related]
17. Exercise in hypertrophic cardiomyopathy: restrict or rethink. Weissler Snir A; Connelly KA; Goodman JM; Dorian D; Dorian P Am J Physiol Heart Circ Physiol; 2021 May; 320(5):H2101-H2111. PubMed ID: 33769918 [TBL] [Abstract][Full Text] [Related]
18. Study design and rationale of VALOR-HCM: evaluation of mavacamten in adults with symptomatic obstructive hypertrophic cardiomyopathy who are eligible for septal reduction therapy. Desai MY; Wolski K; Owens A; Naidu SS; Geske JB; Smedira NG; Schaff H; Lampl K; McErlean E; Sewell C; Zhang D; Edelberg JM; Sehnert AJ; Nissen SE Am Heart J; 2021 Sep; 239():80-89. PubMed ID: 34038706 [TBL] [Abstract][Full Text] [Related]